血清白蛋白、血红蛋白、前白蛋白联合检测评估肺结核的治疗效果

Abstract
Figure/Table
References (15)
Related Citation (7)

Download: PDF (0 KB) HTML (25 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate serum albumin(ALB),hemoglobin(HGB)and prealbumin(PA)in the evaluation of therapeutic effect of pulmonary tuberculosis.Methods147 patients with pulmonary tuberculosis in our hospital from October 2015 to March 2017 were selected as research object.Based on the control of pulmonary tuberculosis patients,serum albumin,hemoglobin and prealbumin in patients with pulmonary tuberculosis before and after treatment were measured to evaluate the therapeutic effect.ResultsThe level of ALB,PA and HGB of the patients with pulmonary tuberculosis increased after treatment,and the difference of ALB and PA after treatment was statistically significant compared with that before treatment(P＜0.001).There was no significant difference in hemoglobin before and after treatment(P=0.245).The change in albumin was not affected by gender(P=0.601)and age(P=0.707),but was positively correlated with hospitalization time (P＜0.001).Prealbumin was not affected by patient sex,age and hospitalization time (P＞0.05).ConclusionThe changes of serum PA and ALB levels can be used as an objective criterion for monitoring the therapeutic effect of pulmonary tuberculosis drugs,and prealbumin is not affected by the gender,age and hospitalization time in patients with tuberculosis.

Key words： Albumin Hemoglobin Prealbumin Pulmonary tuberculosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHENG Song
	CHENG Jie
	LI Mei
	WANG Dian-chao
	PENG Ling

Cite this article:

ZHENG Song,CHENG Jie,LI Mei, et al. Evaluating the therapeutic effect of pulmonary tuberculosis by serum albumin，hemoglobin and prealbumin combined detection[J]. 中国当代医药, 2018, 25(3): 142-144.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I3/142

[1]	WorldHealthOrganization.Globaltuberculosisreport2016[M].Geneva：WHO Press，2016：142-182.
[2]	王慧慧.全省结核病疫情明显下降[N].中安在线-安徽日报.2017-03-24（1）.
[3]	侯婧，张妍蓓.536例老年肺结核患者血清白蛋白、血红蛋白等相关指标分析[J].实用医学杂志，2016，32（1）：134-136.
[4]	侯婧，刘刚，韩莙，等.老年肺结核患者营养指标与疾病相关性分析[J].中国理临床研究，2017，30（4）：459-462.
[5]	胡佳，张鑫，张燕.诊断性抗结核治疗在鉴别肠道克罗恩病与肠结核中的意义[J].四川大学学报（医学版），2015，46（2）：331-335.
[6]	谷强业，刘桂玲，郑辉.前白蛋白检测在抗结核药物致肝损伤中的应用[J].中国医药导刊，2016，18（4）：329-330.
[7]	吕宁，单万水，黄慧谦.检测血清前白蛋白在肺结核治疗中的临床意义[J].中国实用医药，2010，5（3）：171.
[8]	严成浩.血清前白蛋白检测在抗结核药物致肝损伤中的意义[J].中国实验诊断学，2012，16（10）：1906.
[9]	张卫卫，王学清，李岩.血清前白蛋白、胆碱酯酶对判断肝硬化患者肝储备功能及预后的临床价值[J].中国实用内科杂志，2002，22（11）：673-674.
[10]	Menzies D，Benedetti A，Paydar A，et al.Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to Isoniazid：a systematic review and Meta-analysis[J].PLoS Med，2009，6（9）：e1000150.
[11]	吴俊杰，郑强，虞晶.血清白蛋白水平对初治涂阳肺结核患者预后的影响[J].中国现代医药杂志，2016，18（10）：41-43.
[12]	邓念，申昊，苟菊花，张秉强.血清腹水白蛋白梯度的临床应用进展[J].胃肠病和肝病学杂志，2016，25（1）：115-117.
[13]	Jolobe O.Potential risk factors for recurrence of pulmonary tuberculosis[J].Thorax，2011，66（8）：731.
[14]	梁升林，罗凯，廖桂梅.血红蛋白减少对活动性肺结核的临床价值[J].检验医学与临床，2010，7（12）：1244-1245.
[15]	Luo H，Zhu B，Gong L，et al.The value of serum prealbumin in the diagnosis and therapeutic response of tuberculosis：a retrospective study[J].PLoS One，2013，8（11）：e79940.